What is the equity of Resmed this year?
Resmed has equity of 4.86 B USD this year.
Resmed Equity 2024
Resmed Equity
4.86 B USD
Ticker
RMD
ISIN
US7611521078
WKN
895878
In 2024, Resmed's equity was 4.86 B USD, a 44.73% increase from the 3.36 B USD equity in the previous year.
Resmed Aktienanalyse
What does Resmed do?
ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Resmed's Equity
Resmed's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Resmed's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Resmed's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Resmed's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Resmed’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Resmed stock
What was the equity of Resmed compared to the previous year?
The equity of Resmed has increased/decreased by 44.73% increased compared to the previous year.
What impact does a high equity have on investors of Resmed?
A high equity is advantageous for investors of Resmed as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Resmed?
A low equity can be a risk for investors of Resmed, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Resmed affect the company?
An increase in equity of Resmed can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Resmed affect the company?
A reduction in equity of Resmed can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Resmed?
Some factors that can affect the equity of Resmed include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Resmed so important for investors?
The equity of Resmed is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Resmed take to change the equity?
To change equity, Resmed can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Resmed pay?
Over the past 12 months, Resmed paid a dividend of 2.02 USD . This corresponds to a dividend yield of about 0.81 %. For the coming 12 months, Resmed is expected to pay a dividend of 2.31 USD.
What is the dividend yield of Resmed?
The current dividend yield of Resmed is 0.81 %.
When does Resmed pay dividends?
Resmed pays a quarterly dividend. This is distributed in the months of March, June, September, December.
How secure is the dividend of Resmed?
Resmed paid dividends every year for the past 0 years.
What is the dividend of Resmed?
For the upcoming 12 months, dividends amounting to 2.31 USD are expected. This corresponds to a dividend yield of 0.93 %.
In which sector is Resmed located?
Resmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Resmed from 12/12/2024 amounting to 0.53 USD, you needed to have the stock in your portfolio before the ex-date on 11/7/2024.
When did Resmed pay the last dividend?
The last dividend was paid out on 12/12/2024.
What was the dividend of Resmed in the year 2023?
In the year 2023, Resmed distributed 1.84 USD as dividends.
In which currency does Resmed pay out the dividend?
The dividends of Resmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Resmed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Resmed
Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
